Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Keros Therapeutics, Inc. - common stock (NQ:KROS)

11.94 +0.25 (+2.14%)
Streaming Delayed Price Updated: 2:50 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Keros Therapeutics, Inc. - common stock

< Previous 1 2 3 Next >
News headline image
Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst ↗
Takeda inks a licensing deal with Keros for elritercept, a late-stage anemia drug, and plans a Phase 3 trial in myelodysplastic syndromes. 
Via Benzinga
News headline image
Keros Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
 
Via Benzinga
News headline image
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark ↗
Building your watch list, look for stocks with an 80-plus RS Rating. Keros Therapeutics stock just met that criteria with a new score of 86. 
Via Investor's Business Daily
News headline image
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
KROS Stock Earnings: Keros Therapeutics Misses EPS for Q2 2024 ↗
KROS stock results show that Keros Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Keros Therapeutics Inc. (NASDAQ: KROS) Near the Top of Equities by Percentage Gain on 1/4
Via Investor Brand Network
News headline image
Where Keros Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Recap: Keros Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
Recap: Keros Therapeutics Q3 Earnings ↗
Keros Therapeutics (NASDAQ:KROS) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth ↗
Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation. Oppenheimer rates KROS Outperform with a $102 price target. 
Via Benzinga
News headline image
KROS Stock Earnings: Keros Therapeutics Beats EPS for Q1 2024 ↗
KROS stock results show that Keros Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Keros Therapeutics Posts Preliminary Data Early-Stage KER-012 Trial ↗
 
Via Benzinga
News headline image
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.< 
Via Benzinga
News headline image
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following... 
Via Benzinga
Topics Stocks
News headline image
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the... 
Via Benzinga
News headline image
Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023 ↗
 
Via Benzinga
News headline image
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827. 
Via Benzinga
News headline image
Why Shares of Keros Therapeutics Jumped This Week ↗
The company appointed a new director and an analyst reiterated his position on the stock. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023 ↗
 
Via Benzinga
BioMedNewsBreaks – Keros Therapeutics Inc. (NASDAQ: KROS) Presents Clinical and Preclinical Data from Its Lead Hematological Programs at 64th ASH Event
Via Investor Brand Network
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Why Shares of Keros Therapeutics Rose 10.2% This Week ↗
A sympathetic reaction to a competitor's drug helped push the clinical-stage pharmaceutical company's shares higher. 
Via The Motley Fool
News headline image
Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Monday. Here are some big stocks recording gained in today’s session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022 ↗
Upgrades 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 216 stocks hit new 52-week lows. 
Via Benzinga
News headline image
76 Biggest Movers From Yesterday ↗
Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.